Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
FORA Stock Forecast 2026-2027
$2.05
Current Price
$63.70M
Market Cap
Buy 0
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to FORA Price Targets
+2.4%
To High Target of $2.10
+2.4%
To Median Target of $2.10
+2.4%
To Low Target of $2.10
FORA Price Momentum
-1.4%
1 Week Change
-2.4%
1 Month Change
-1.0%
1 Year Change
-3.3%
Year-to-Date Change
-24.4%
From 52W High of $2.71
+25.0%
From 52W Low of $1.64
📊 TOP ANALYST CALLS
Did FORA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Forian is one of their latest high-conviction picks.
Latest FORA Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, FORA has a neutral consensus with a median price target of $2.10 (ranging from $2.10 to $2.10). The overall analyst rating is N/A (N/A/10). Currently trading at $2.05, the median forecast implies a 2.4% upside. This outlook is supported by 0 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
FORA Analyst Ratings
0
Buy
1
Hold
0
Sell
FORA Price Target Range
Low
$2.10
Average
$2.10
High
$2.10
Current: $2.05
Latest FORA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for FORA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 14, 2024 | Roth MKM | Richard Baldry | Buy | Reiterates | $5.00 |
| Apr 4, 2024 | Roth MKM | Richard Baldry | Buy | Reiterates | $5.00 |
| Dec 20, 2023 | Roth MKM | Richard Baldry | Buy | Initiates | $5.00 |
| Aug 11, 2023 | Lake Street | Eric Martinuzzi | Buy | Maintains | $5.00 |
| Nov 10, 2022 | RBC Capital | Drew McReynolds | Outperform | Maintains | $17.00 |
| Apr 8, 2022 | Lake Street | Eric Martinuzzi | Buy | Initiates | $9.00 |
Forian Inc. (FORA) Competitors
The following stocks are similar to Forian based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Forian Inc. (FORA) Financial Data
Forian Inc. has a market capitalization of $63.70M with a P/E ratio of 68.0x. The company generates $28.11M in trailing twelve-month revenue with a -3.0% profit margin.
Revenue growth is +65.6% quarter-over-quarter, while maintaining an operating margin of -6.1% and return on equity of -2.9%.
Valuation Metrics
Market Cap
$63.70M
Enterprise Value
$35.49M
P/E Ratio
68.0x
PEG Ratio
-0.7x
Price/Sales
2.3x
Growth & Margins
Revenue Growth (YoY)
+65.6%
Gross Margin
+51.6%
Operating Margin
-6.1%
Net Margin
-3.0%
EPS Growth
+65.6%
Financial Health
Cash/Price Ratio
+44.3%
Current Ratio
3.9x
Debt/Equity
0.1x
ROE
-2.9%
ROA
-4.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Forian Inc. (FORA) Business Model
About Forian Inc.
What They Do
Provides data analytics for healthcare and cannabis.
Business Model
The company generates revenue by offering integrated data solutions and analytics services to clients in the healthcare and cannabis industries. By leveraging its proprietary technology, Forian Inc. enhances operational efficiencies and patient outcomes, while also ensuring regulatory compliance for its clients. Its focus on specialized market research and information management allows it to cater to the unique needs of pharmaceutical, biotechnology, and legal cannabis businesses.
Additional Information
Forian Inc. positions itself as a vital partner in emerging and regulated industries, helping clients streamline operations and foster innovation. Its comprehensive data services and technology support informed decision-making and provide a competitive advantage in the marketplace.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
47
CEO
Mr. Max C. Wygod
Country
United States
IPO Year
2020
Website
forian.comForian Inc. (FORA) Latest News & Analysis
Latest News
Quick Summary
VerticalScope Holdings Inc. announced its Q4 2025 earnings results. For detailed insights, refer to the full earnings call transcript.
Why It Matters
VerticalScope's Q4 earnings call provides insights into financial performance, growth prospects, and market trends, influencing investor sentiment and potential stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
VerticalScope Reports Fourth Quarter and Full Year 2025 Results; Achieves Full-Year Adjusted EBITDA Guidance
11 days ago
Quick Summary
VerticalScope Holdings Inc. (TSX: FORA) reported its Q4 2025 financial results, emphasizing business resilience and a strong community-driven audience, according to CEO Chris Goodridge.
Why It Matters
VerticalScope's Q4 financial results showcase business resilience and a strong audience, indicating potential for future growth and stability, which can influence investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
VerticalScope Holdings Inc. (TSX: FORA; OTCQX: VFORF) will release Q4 and full year 2025 results on March 3, 2026, with a conference call on March 4 at 8:00 a.m. ET.
Why It Matters
VerticalScope's upcoming earnings release and conference call indicate key financial performance insights, influencing stock valuation and investor sentiment around its future growth.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks Computer - Services companies PDFS, WYY, and FORA are expected to gain from digital transformation trends, despite facing macroeconomic challenges.
Why It Matters
Digital transformation trends signal growth opportunities for companies like PDFS, WYY, and FORA, potentially enhancing their market performance amid economic challenges.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Forian Inc. (FORA) will hold its Q3 2025 earnings call on November 14, 2025, at 4:30 PM EST, featuring CEO Max Wygod and CFO Michael Vesey.
Why It Matters
Forian Inc.'s Q3 2025 earnings call indicates upcoming financial results, which can impact stock performance and investor sentiment based on company performance and future outlook.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
VerticalScope Holdings Inc. will hold its Q3 2025 earnings call on November 6, 2025, at 8:00 AM EST, featuring CEO Christopher Goodridge and CFO Vincenzo Bellissimo.
Why It Matters
VerticalScope's Q3 2025 earnings call provides insights into its financial performance, strategic direction, and future prospects, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About FORA Stock
What is Forian Inc.'s (FORA) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Forian Inc. (FORA) has a median price target of $2.10. The highest price target is $2.10 and the lowest is $2.10.
Is FORA stock a good investment in 2026?
According to current analyst ratings, FORA has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.05. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for FORA stock?
Wall Street analysts predict FORA stock could reach $2.10 in the next 12 months. This represents a 2.4% increase from the current price of $2.05. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Forian Inc.'s business model?
The company generates revenue by offering integrated data solutions and analytics services to clients in the healthcare and cannabis industries. By leveraging its proprietary technology, Forian Inc. enhances operational efficiencies and patient outcomes, while also ensuring regulatory compliance for its clients. Its focus on specialized market research and information management allows it to cater to the unique needs of pharmaceutical, biotechnology, and legal cannabis businesses.
What is the highest forecasted price for FORA Forian Inc.?
The highest price target for FORA is $2.10 from at , which represents a 2.4% increase from the current price of $2.05.
What is the lowest forecasted price for FORA Forian Inc.?
The lowest price target for FORA is $2.10 from at , which represents a 2.4% increase from the current price of $2.05.
What is the overall FORA consensus from analysts for Forian Inc.?
The overall analyst consensus for FORA is neutral. Out of 3 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $2.10.
How accurate are FORA stock price projections?
Stock price projections, including those for Forian Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 15, 2026 4:20 AM UTC